跳至主要内容
临床试验/NCT02254460
NCT02254460已完成不适用

A Double Blind, Randomized, Two-way Cross-over Study to Investigate the Uptake of Iron From Micronutrient Fortified Powder vs. From Tailored Control in Milk.

GlaxoSmithKline2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2013年2月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Fractional Iron Absorption

研究概览

简要总结

The present study supplements iron as part of multiple micro-nutrient supplementation to demonstrate that intake of a micronutrient fortified powder in milk helps increase the uptake of key micronutrients like iron due to unique nature of the given matrix, as compared to intake of iron alone in milk.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
7 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Demonstrates understanding of the study and willingness to participate as evidenced by participants' parents and/or legal guardian's voluntary written informed consent as well as written assent by the participant and has received a signed and dated copy of the informed consent form as well as the assent form
  • Participant belonging to middle socio-economic background as per modified Kuppuswamy scale
  • Good general and mental health with, in the opinion of the investigator or medically qualified designee
  • Child residing in the peri-urban areas of Bangalore city
  • Child with Z-scores of: a. height for age of 0 to ≥-3; b. BMI for age of 0 to ≥-3.

排除标准

  • Children in Care (CiC)
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds), any of their stated ingredients or any known food allergies like peanut allergy, gluten allergy or lactose intolerance
  • Participants with severe anaemia (Haemoglobin < 8g %) as determined by laboratory results
  • Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any medical disorder that would make the participant unlikely to fully complete the study or any condition that presents undue risk from the study product or procedures in the opinion of the investigator
  • Recent history (3 months) of serious infections, injuries and/ or surgeries
  • Children consuming iron, calcium and/or other nutritional supplements and/ or health food drinks on a regular basis (more than 3 times a week) in last 6 months prior to screening visit
  • Use of any prescription medications within 15 days prior to screening and throughout the entire duration of the study
  • Recent history (within the last 1 year) of alcohol or other substance abuse.

研究组 & 干预措施

Test

Experimental

Experimental product: Micronutrient fortified beverage powder, packed as 27 g individual sachet, administered orally as a single serve.

干预措施: Test (Dietary Supplement)

Control

Placebo Comparator

Energy equivalent beverage powder without micronutrient fortification, packed as 27 g individual sachets, administered orally as a single serve

干预措施: Control (Other)

结局指标

主要结局

Fractional Iron Absorption

时间窗: Day 15

Iron uptake was measured using stable isotopes of 57Fe and 58Fe to label the test and control products. Fractional iron absorption levels of 57Fe and 58Fe were calculated, to give a direct measure of the iron uptake from each of the study treatments.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验